Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Other Operating Expenses (2018 - 2025)

AVITA Medical's Other Operating Expenses history spans 8 years, with the latest figure at $11.9 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 15.39% year-over-year to $11.9 million; the TTM value through Dec 2025 reached $53.1 million, down 8.69%, while the annual FY2025 figure was $53.1 million, 8.69% down from the prior year.
  • Other Operating Expenses reached $11.9 million in Q4 2025 per RCEL's latest filing, down from $12.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $16.3 million in Q2 2024 to a low of $59000.0 in Q4 2023.
  • Average Other Operating Expenses over 5 years is $6.2 million, with a median of $904000.0 recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: plummeted 94.25% in 2023, then surged 23813.56% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $374000.0 in 2021, then soared by 174.33% to $1.0 million in 2022, then tumbled by 94.25% to $59000.0 in 2023, then soared by 23813.56% to $14.1 million in 2024, then dropped by 15.39% to $11.9 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Other Operating Expenses are $11.9 million (Q4 2025), $12.1 million (Q3 2025), and $14.3 million (Q2 2025).